GENEVA--(BUSINESS WIRE)-- Alcon Inc. ("Alcon") (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into a settlement ...

The Federal Trade Commission said the transaction had threatened to raise prices and stifle innovation for cataract laser eye ...

Under the original agreement, Lensar will retain a $10m deposit.

LENSAR (NASDAQ:LNSR) executives used the company’s fourth-quarter and full-year 2025 earnings call to outline how the ...

(RTTNews) - Alcon Inc. (ALC) said that it has reached an agreement with J&J Surgical Vision Inc. to settle their pending legal proceedings relating to femtosecond laser assisted cataract surgery ...

Alcon agreed to buy LENSAR for $14.00/share cash, integrating ALLY, Streamline, and the legacy laser system to expand FLACS ...

Alcon’s LenSx femtosecond laser may be the most significant piece of technology to impact cataract surgery in recent years, allowing surgeons to correct astigmatism in cataract patients by creating ...

Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon’s cataract equipment and technology portfolio Next generation technology will be expanded globally, improving the efficiency of ...

Swiss eyecare giant Alcon has agreed to pay rival Johnson & Johnson (J&J) $199 million as part of a legal settlement surrounding the use of femtosecond lasers in cataract surgery. The ...

Alcon, the multinational pharmaceuticals company specializing in eye care, has agreed a deal to acquire cataract laser surgery pioneer Lensar. The deal, valued at up to $430 million, will expand Alcon ...

Lensar has some rebuilding to do now that a merger with Alcon has fallen through, according to a BTIG analyst. To recap, ...